UAE批准为轻度认知障碍/痴呆病人治疗阿尔茨海默氏氏病的Leqembi。 UAE approves Leqembi, an Alzheimer's treatment, for mild cognitive impairment/mild dementia patients.

阿联酋卫生部批准对有轻度认知障碍或轻度痴呆的病人进行老年痴呆症治疗Leqembi(Lecanemab)。 The UAE Ministry of Health approves Leqembi (lecanemab), an Alzheimer's treatment, for patients with mild cognitive impairment or mild dementia. Leqembi由BioArctic和Eisai开发,旨在降低疾病发展速度以及缓慢的认知和功能下降。 Developed by BioArctic and Eisai, Leqembi is designed to reduce the rate of disease progression and slow cognitive and functional decline. 这标志着本区域首次批准针对阿尔茨海默氏病病理学的治疗。 This marks the first approval in the region for a treatment targeting Alzheimer's disease pathology.